Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vaporm

Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2022

What 6 Analyst Ratings Have To Say About Vapotherm

What 6 Analyst Ratings Have To Say About Vapotherm

Analysts have provided the following ratings for Vapotherm (NYSE:VAPO) within the last quarter:

Looking Into Vapotherm's Return On Capital Employed

Looking Into Vapotherm's Return On Capital Employed

Benzinga Pro data, Vapotherm (NYSE:VAPO) reported Q1 sales of $21.62 million. Earnings fell to a loss of $22.94 million, resulting in a 23.59% decrease from last quarter.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

What 4 Analyst Ratings Have To Say About Vapotherm

Within the last quarter, Vapotherm (NYSE:VAPO) has observed the following analyst ratings:

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

Recap: Vapotherm Q1 Earnings

Vapotherm (NYSE:VAPO) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings Vapotherm missed estimated earnings by 29.69%, reporting an EPS of $-0.83 versus an estimate of $-0.64.

Canaccord Genuity Maintains Buy Rating for Vapotherm, Lowers Price Target To $12

Canaccord Genuity has decided to maintain its Buy rating of Vapotherm (NYSE:VAPO) and lower its price target from $21.00 to $12.00. Shares of Vapotherm are trading down 1.52% over the last 24 hours, at $6.48 per share.

inkl

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play